
The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient advocates. A newly discovered subtype of Castleman disease promises to improve diagnosis and treatment for thousands of patients who have not fit neatly into existing classifications. Named Oligocentric Castleman Disease (OligoCD), this distinct clinical entity differs significantly [...]